Showing results (11-20 of 146) with videos related to
Sort By:
Pageof 15
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2011
How current understanding of clearance mechanisms and pharmacodynamics of therapeutic proteins can be applied for evaluation of their drug-drug interaction potentialEugenia Kraynov, Steven W Martin, Susan Hurst, et al.Expert Review of Clinical Pharmacology|November 25, 2011
Superparamagnetic iron oxide nanoparticle 'theranostics' for multimodality tumor imaging, gene delivery, targeted drug and prodrug deliveryYanke Yu, Duxin SunCancer Chemotherapy and Pharmacology|September 1, 2006
Pharmacodynamic and toxicokinetic evaluation of the novel MEK inhibitor, PD0325901, in the rat following oral and intravenous administrationAlan P Brown, Tage C G Carlson, Cho-Ming Loi, et al.Drug Metabolism Letters|April 10, 2009
Application of in-line liquid chromatography-accurate radioisotope counting-mass spectrometry (LC-ARC-MS) to evaluate metabolic profile of [3H]-mefenamic acid in rat plasmaWing Lam, Cho-Ming Loi, James Atherton, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 31, 2009
Cross-species comparison of the metabolism and excretion of zoniporide: contribution of aldehyde oxidase to interspecies differencesDeepak Dalvie, Chenghong Zhang, Weichao Chen, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 13, 2020
A physiological model of granulopoiesis to predict clinical drug induced neutropenia from in vitro bone marrow studies: with application to a cell cycle inhibitorWenbo Chen, Britton Boras, Tae Sung, et al.Cancer Chemotherapy and Pharmacology|June 14, 2013
A phase I, open-label, mass balance study of [(14)C] dacomitinib (PF-00299804) in healthy male volunteersCarlo L Bello, Evan Smith, Ana Ruiz-Garcia, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|September 6, 2005
Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicityJennifer L Seachrist, Cho-Ming Loi, Mark G Evans, et al.Anti-Cancer Drugs|March 16, 2019
Talazoparib has no clinically relevant effect on QTc interval in patients with advanced solid tumorsJustin Hoffman, Jayeta Chakrabarti, Anna Plotka, et al.International Journal of Pharmaceutics|December 1, 2009
Biodistribution of HuCC49DeltaCH2-beta-galactosidase in colorectal cancer xenograft modelYanke Yu, Lanyan Fang, Duxin SunPageof 15